BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23430009)

  • 1. Thromboembolic disease in cancer patients.
    Hindi N; Cordero N; Espinosa E
    Support Care Cancer; 2013 May; 21(5):1481-6. PubMed ID: 23430009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Drugs; 1996 Jul; 52(1):71-92. PubMed ID: 8799686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients.
    Lee AY
    Curr Opin Pulm Med; 2003 Sep; 9(5):351-5. PubMed ID: 12904702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous thromboembolism in cancer patients.
    Lee AY
    Thromb Res; 2001 Jun; 102(6):V195-208. PubMed ID: 11516453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer, coagulation, and anticoagulation.
    Letai A; Kuter DJ
    Oncologist; 1999; 4(6):443-9. PubMed ID: 10631688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
    Zacharski LR; Prandoni P; Monreal M
    Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit assessment of anticoagulant therapy.
    Harrington R; Ansell J
    Drug Saf; 1991; 6(1):54-69. PubMed ID: 2029354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomena.
    Quick D; Trowbridge AA
    Postgrad Med; 1984 Dec; 76(8):151-4, 156, 158-62. PubMed ID: 6504795
    [No Abstract]   [Full Text] [Related]  

  • 12. Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysis.
    Dranitsaris G; Vincent M; Crowther M
    Pharmacoeconomics; 2006; 24(6):593-607. PubMed ID: 16761906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prophylaxis of venous thromboembolism during pregnancy.
    Bates SM
    Thromb Res; 2002 Nov; 108(2-3):97-106. PubMed ID: 12590944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding and thrombotic events occur early in children on durable ventricular assist devices.
    Huang JY; Ignjatovic V; Sheridan BJ; Mathew J; D'Udekem Y; Brink J; Barton R; Callea G; Morsman D; Donath S; Opat S; Monagle P
    Thromb Res; 2019 Jan; 173():65-70. PubMed ID: 30476715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of thromboembolic complications in patients with brain tumors.
    Norris LK; Grossman SA
    J Neurooncol; 1994; 22(2):127-37. PubMed ID: 7745465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.